Trademark: 90979307
Word
BASEJUMPER
Status
Registered
Status Code
700
Status Date
Tuesday, April 18, 2023
Serial Number
90979307
Registration Number
7032252
Registration Date
Tuesday, April 18, 2023
Mark Type
4000
Filing Date
Wednesday, March 24, 2021
Published for Opposition
Tuesday, March 8, 2022

Trademark Owner History
BIOSKRYB GENOMICS, INC. - Original Registrant
BioSkryb, Inc. - Original Applicant

Classifications
42 Genomic, proteomic, transcriptomic, epigenomic, metabolomic, and microbiomic analysis and sequencing services for scientific and research purposes; providing scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; nucleic acid and ribonucleic acid analysis services for scientific research purposes; platform as a service (PAAS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; software as a service (SAAS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for the purpose of allowing users to evaluate data quality, compare results between cells and samples, and integrate multi-omics data; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for evaluating data, namely, sequencing alignment, coverage, and single nucleotide, structural, and copy number variant calling metrics; providing temporary use of non-downloadable computer software for genomic analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software for medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for nucleic acid and ribonucleic acid analysis for medical and scientific research purposes; providing temporary use of non-downloadable computer software for providing medical and scientific research information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; providing temporary use of non-downloadable computer software for medical and scientific research in connection with high-quality single-cell and low-input DNA amplification, primary template-directed amplification (PTA) reaction and library cleanup, optimum bead cleanup performance, single-cell and low-input transcriptional profiling, and combined genome and transcriptome profiling; providing temporary use of non-downloadable computer software for medical and scientific research in connection with genome amplification to detect genetic variants in cells; providing temporary use of non-downloadable computer software for medical and scientific research in connection with measuring genetic diversity in single cells; providing temporary use of non-downloadable computer software for medical and scientific research in connection with primary template-directed amplification for use in connection with single cells and ultra-low DNA input samples; providing temporary use of non-downloadable computer software for medical and scientific research for the purpose of elevating single cell genome variants for the purpose of genome amplification; providing temporary use of non-downloadable computer software for DNA analysis and sequencing for scientific, medical, and research purposes; providing temporary use of non-downloadable computer software for research, development and consultancy in the field of genomics; providing temporary use of non-downloadable computer software for compiling data for research purposes in the field of genomics; providing temporary use of non-downloadable computer software for providing medical research information in the field of genomics, gene therapy, cell therapy for medical purposes; providing temporary use of non-downloadable computer software for medical testing, diagnosis, and treatment; providing temporary use of non-downloadable computer software for bioinformatic DNA sequencing analysis for biomarker discovery and annotation for use in connection with offering medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing temporary use of non-downloadable computer software for use in connection with medical diagnostic testing, monitoring, and reporting; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in connection with the fields of oncology, cardiology, prenatal genetic testing (PGT), neurological genetic disorders, immunology, microbiome, toxicology, and bioprocessing; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the field of gene therapy and cell therapy; providing temporary use of non-downloadable computer software for medical analysis and diagnosis in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics
BASE JUMPER

Trademark Events
Apr 18, 2023
Notice Of Registration Confirmation Emailed
Apr 18, 2023
Registered-Principal Register
Mar 11, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 10, 2023
Allowed Principal Register - Sou Accepted
Mar 9, 2023
Statement Of Use Processing Complete
Dec 29, 2022
Use Amendment Filed
Mar 9, 2023
Divisional Processing Complete
Dec 29, 2022
Divisional Request Received
Mar 3, 2023
Case Assigned To Intent To Use Paralegal
Jan 30, 2023
Case Assigned To Intent To Use Paralegal
Dec 29, 2022
Teas Request To Divide Received
Dec 29, 2022
Teas Statement Of Use Received
Nov 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 31, 2022
Sou Extension 1 Granted
Oct 31, 2022
Sou Extension 1 Filed
Oct 31, 2022
Teas Extension Received
May 3, 2022
Noa E-Mailed - Sou Required From Applicant
Mar 8, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 8, 2022
Published For Opposition
Feb 16, 2022
Notification Of Notice Of Publication E-Mailed
Feb 1, 2022
Approved For Pub - Principal Register
Jan 31, 2022
Teas/Email Correspondence Entered
Jan 31, 2022
Correspondence Received In Law Office
Jan 31, 2022
Teas Response To Office Action Received
Sep 17, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 17, 2021
Teas Change Of Correspondence Received
Sep 17, 2021
Teas Change Of Owner Address Received
Aug 2, 2021
Notification Of Non-Final Action E-Mailed
Aug 2, 2021
Non-Final Action E-Mailed
Aug 2, 2021
Non-Final Action Written
Jul 26, 2021
Assigned To Examiner
Jul 1, 2021
New Application Office Supplied Data Entered
Jun 2, 2021
Automatic Update Of Assignment Of Ownership
Mar 27, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24